Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

The pluripotency factor NANOG promotes the formation of squamous cell carcinomas.

Palla AR, Piazzolla D, Alcazar N, Cañamero M, Graña O, Gómez-López G, Dominguez O, Dueñas M, Paramio JM, Serrano M.

Sci Rep. 2015 May 19;5:10205. doi: 10.1038/srep10205.

PMID:
25988972
2.

Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency.

Piquer Gibert M, Alsina L, Giner Muñoz MT, Cruz Martínez O, Ruiz Echevarria K, Dominguez O, Plaza Martín AM, Arostegui JI, de Valles G, Juan Otero M, Martin-Mateos MA.

Eur J Pediatr. 2015 Mar 10. [Epub ahead of print]

PMID:
25749928
3.

Impact of oral immunotherapy on quality of life in egg-allergic children.

Vazquez-Ortiz M, Alvaro M, Piquer M, Dominguez O, Giner MT, Lozano J, Jiménez-Feijoo R, Plaza AM.

Pediatr Allergy Immunol. 2015 May;26(3):291-4. doi: 10.1111/pai.12355. No abstract available.

PMID:
25692393
4.

Genome-wide analysis of in vivo TRF1 binding to chromatin restricts its location exclusively to telomeric repeats.

Garrobo I, Marión RM, Domínguez O, Pisano DG, Blasco MA.

Cell Cycle. 2014;13(23):3742-9. doi: 10.4161/15384101.2014.965044.

PMID:
25483083
5.

Identification of TERRA locus unveils a telomere protection role through association to nearly all chromosomes.

López de Silanes I, Graña O, De Bonis ML, Dominguez O, Pisano DG, Blasco MA.

Nat Commun. 2014 Sep 3;5:4723. doi: 10.1038/ncomms5723.

6.

Life-threatening anaphylaxis to egg and milk oral immunotherapy in asthmatic teenagers.

Vazquez-Ortiz M, Alvaro M, Piquer M, Giner MT, Dominguez O, Lozano J, Jiménez-Feijoo R, Cambra FJ, Plaza AM.

Ann Allergy Asthma Immunol. 2014 Oct;113(4):482-4. doi: 10.1016/j.anai.2014.07.010. Epub 2014 Aug 19. No abstract available.

PMID:
25153996
7.

Exome sequencing of three cases of familial exceptional longevity.

Cash TP, Pita G, Domínguez O, Alonso MR, Moreno LT, Borrás C, Rodríguez-Mañas L, Santiago C, Garatachea N, Lucia A, Avellana JA, Viña J, González-Neira A, Serrano M.

Aging Cell. 2014 Dec;13(6):1087-90. doi: 10.1111/acel.12261. Epub 2014 Aug 12.

8.

Tolerance to egg proteins in egg-sensitized infants without previous consumption.

Alvaro M, García-Paba MB, Giner MT, Piquer M, Domínguez O, Lozano J, Jiménez R, Machinena A, Martín-Mateos MA, Plaza AM.

Allergy. 2014 Oct;69(10):1350-6. doi: 10.1111/all.12483. Epub 2014 Aug 22.

PMID:
25040899
9.

Predicting reactions severity at challenge in egg-allergic patients.

Vazquez-Ortiz M, Alvaro M, Piquer M, Dominguez O, Machinena A, Martín-Mateos MA, Plaza AM.

Clin Exp Allergy. 2014 Aug;44(8):1096-7. doi: 10.1111/cea.12364. No abstract available.

PMID:
24985746
10.

Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia.

Piazzolla D, Palla AR, Pantoja C, Cañamero M, de Castro IP, Ortega S, Gómez-López G, Dominguez O, Megías D, Roncador G, Luque-Garcia JL, Fernandez-Tresguerres B, Fernandez AF, Fraga MF, Rodriguez-Justo M, Manzanares M, Sánchez-Carbayo M, García-Pedrero JM, Rodrigo JP, Malumbres M, Serrano M.

Nat Commun. 2014 Jun 30;5:4226. doi: 10.1038/ncomms5226.

PMID:
24979572
11.

PLCG1 mutations in cutaneous T-cell lymphomas.

Vaqué JP, Gómez-López G, Monsálvez V, Varela I, Martínez N, Pérez C, Domínguez O, Graña O, Rodríguez-Peralto JL, Rodríguez-Pinilla SM, González-Vela C, Rubio-Camarillo M, Martín-Sánchez E, Pisano DG, Papadavid E, Papadaki T, Requena L, García-Marco JA, Méndez M, Provencio M, Hospital M, Suárez-Massa D, Postigo C, San Segundo D, López-Hoyos M, Ortiz-Romero PL, Piris MA, Sánchez-Beato M.

Blood. 2014 Mar 27;123(13):2034-43. doi: 10.1182/blood-2013-05-504308. Epub 2014 Feb 4.

12.

Baseline specific IgE levels are useful to predict safety of oral immunotherapy in egg-allergic children.

Vazquez-Ortiz M, Alvaro M, Piquer M, Dominguez O, Machinena A, Martín-Mateos MA, Plaza AM.

Clin Exp Allergy. 2014 Jan;44(1):130-41. doi: 10.1111/cea.12233.

PMID:
24355019
13.

Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.

Balbás-Martínez C, Sagrera A, Carrillo-de-Santa-Pau E, Earl J, Márquez M, Vazquez M, Lapi E, Castro-Giner F, Beltran S, Bayés M, Carrato A, Cigudosa JC, Domínguez O, Gut M, Herranz J, Juanpere N, Kogevinas M, Langa X, López-Knowles E, Lorente JA, Lloreta J, Pisano DG, Richart L, Rico D, Salgado RN, Tardón A, Chanock S, Heath S, Valencia A, Losada A, Gut I, Malats N, Real FX.

Nat Genet. 2013 Dec;45(12):1464-9. doi: 10.1038/ng.2799. Epub 2013 Oct 13.

14.

Reprogramming in vivo produces teratomas and iPS cells with totipotency features.

Abad M, Mosteiro L, Pantoja C, Cañamero M, Rayon T, Ors I, Graña O, Megías D, Domínguez O, Martínez D, Manzanares M, Ortega S, Serrano M.

Nature. 2013 Oct 17;502(7471):340-5. doi: 10.1038/nature12586. Epub 2013 Sep 11.

PMID:
24025773
15.

Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer.

Palla AR, Piazzolla D, Abad M, Li H, Dominguez O, Schonthaler HB, Wagner EF, Serrano M.

Oncogene. 2014 May 8;33(19):2513-9. doi: 10.1038/onc.2013.196. Epub 2013 Jun 10.

PMID:
23752184
16.

ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.

Balbás-Martínez C, Rodríguez-Pinilla M, Casanova A, Domínguez O, Pisano DG, Gómez G, Lloreta J, Lorente JA, Malats N, Real FX.

PLoS One. 2013 May 1;8(5):e62483. doi: 10.1371/journal.pone.0062483. Print 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/6e83489b-e1ff-4523-9b31-08c90fa39030.

17.

Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles.

Gracia-Aznarez FJ, Fernandez V, Pita G, Peterlongo P, Dominguez O, de la Hoya M, Duran M, Osorio A, Moreno L, Gonzalez-Neira A, Rosa-Rosa JM, Sinilnikova O, Mazoyer S, Hopper J, Lazaro C, Southey M, Odefrey F, Manoukian S, Catucci I, Caldes T, Lynch HT, Hilbers FS, van Asperen CJ, Vasen HF, Goldgar D, Radice P, Devilee P, Benitez J.

PLoS One. 2013;8(2):e55681. doi: 10.1371/journal.pone.0055681. Epub 2013 Feb 8.

18.

A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG.

Lozano-Blasco J, Martín-Mateos MA, Alsina L, Domínguez O, Giner MT, Piquer M, Alvaro M, Plaza AM.

Allergol Immunopathol (Madr). 2014 Mar-Apr;42(2):136-41. doi: 10.1016/j.aller.2012.10.006. Epub 2012 Dec 17.

PMID:
23253680
19.

Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest.

Hidalgo I, Herrera-Merchan A, Ligos JM, Carramolino L, Nuñez J, Martinez F, Dominguez O, Torres M, Gonzalez S.

Cell Stem Cell. 2012 Nov 2;11(5):649-62. doi: 10.1016/j.stem.2012.08.001.

20.

Reply to correspondence letter by M. Korppi.

Álvaro M, Giner MT, Vázquez M, Lozano J, Domínguez O, Piquer M, Días M, Jiménez R, Martín MA, Alsina L, Plaza AM.

Eur J Pediatr. 2013 Feb;172(2):283-4. doi: 10.1007/s00431-012-1877-3. Epub 2012 Nov 1. No abstract available.

PMID:
23114848
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk